Case 1:07-cv-00229-Gl\/IS Document 59 Filed 02/22/2008 Page 1 of 1
F21c|—nAaos, tmrron 5. FINGER
A PROFESSIONAL ASEOCIAYION
one Realm sonata;
920 NoRn+ Kino Smear
KELLY E FARNAN VVll.¥~élNG'T"ON, DELAWARE roam Draecr Dum. Nuwseew
ceoaa ee nvvoo 30265 "`7"'O5
Fax: l30&l55l-77OI F"“""`“@'â€â€œ" WM
www me com
February 22, 2008
BY E-FILING
The lionorable Gregory M. Sleet
United States District Court
J. Caleb Boggs Federal Building
844 N. King Street
Wilmington, Delaware 19301
Re: Merck & Co., Inc. v. Ranbaxy Inc., et al., C.A. N0. 07··229
Dear Chief Judge Sleet:
Pursuant to District of Delaware Local Rule 7.1.4, Defendants Ranbaxy, lnc. and
Ranbaxy Laboratories, Inc. (collectively, "Ranbaxyâ€â€™) respectfully request that Your Honor hear
oral argument on Plaintiff l\/Iercl; & Co., Inc.’s Motion for Leave to File its First Supplemental
Complaint (Di. 48).
If Your Honor has any questions, counsel is available at the Courts convenience.
Respecttiilly,
lcééfitdr fl, Qll/K-/\.eyL»
Kelly E. Farnan (#4395)
KEF.tl1
Enclosure
cc: Mary B. Graham, Esq. (via CM/ECF)
Rrr1»22se1v3»1